Abstract
BACKGROUND: The measles, mumps and rubella (MMR) vaccine has been the focus of considerable adverse publicity in recent years. AIM: To describe recent trends in parental attitudes to, and coverage of, MMR vaccine. DESIGN OF STUDY: Routine surveillance of vaccine coverage and cross-sectional surveys of parental attitudes. SETTING: All health authorities in England (vaccine coverage) and 132 enumeration districts in England (attitude survey). METHOD: Quarterly MMR vaccine coverage for all resident children in England at two years of age was requested from computerised child health information systems. Data was also obtained from 26 English health authorities/trusts on MMR coverage at 16 months of age. The proportion of mothers who believed that MMR vaccine was safe or carried only a slight risk, and the proportion who intended to fully vaccinate any future children, was obtained from biannual interviews with a national representative sample of over 1000 mothers of children under three years of age. RESULTS: Vaccine coverage at two years of age fell 8.6% (95% confidence interval [CI] = 8.4 to 8.8) between April and June 1995 and between April and June 2001. In September 2001, 67% of mothers reported that the MMR vaccine was safe or carried only a slight risk and 92% of mothers agreed with the statement: 'If I had another child in the future I would have them fully immunised against all childhood diseases'. CONCLUSIONS: Despite considerable adverse publicity, the fall in MMR coverage has been relatively small, mothers' attitudes to MMR remain positive, and most continue to seek advice on immunisation from health professionals. As the vast majority of mothers are willing to have future children fully immunised, we believe that health professionals should be able to use the available scientific evidence to help to maintain MMR coverage.
Full Text
The Full Text of this article is available as a PDF (77.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chen R. T., DeStefano F. Vaccine adverse events: causal or coincidental? Lancet. 1998 Feb 28;351(9103):611–612. doi: 10.1016/S0140-6736(05)78423-3. [DOI] [PubMed] [Google Scholar]
- Clark A., Marshall R. Measles, mumps, and rubella vaccine coverage in 2 year old children in East Lancashire--better than it looks. Commun Dis Public Health. 1999 Jan;2(1):50–53. [PubMed] [Google Scholar]
- Evans M., Stoddart H., Condon L., Freeman E., Grizzell M., Mullen R. Parents' perspectives on the MMR immunisation: a focus group study. Br J Gen Pract. 2001 Nov;51(472):904–910. [PMC free article] [PubMed] [Google Scholar]
- Gangarosa E. J., Galazka A. M., Wolfe C. R., Phillips L. M., Gangarosa R. E., Miller E., Chen R. T. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet. 1998 Jan 31;351(9099):356–361. doi: 10.1016/s0140-6736(97)04334-1. [DOI] [PubMed] [Google Scholar]
- Miller E., Waight P. Measles, measles vaccination, and Crohn's disease. Second immunisation has not affected incidence in England. BMJ. 1998 Jun 6;316(7146):1745–1745. [PMC free article] [PubMed] [Google Scholar]
- Panagiotopoulos T., Antoniadou I., Valassi-Adam E. Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review. BMJ. 1999 Dec 4;319(7223):1462–1467. doi: 10.1136/bmj.319.7223.1462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pebody R. G., Paunio M., Ruutu P. Measles, measles vaccination, and Crohn's disease. Crohn's disease has not increased in Finland. BMJ. 1998 Jun 6;316(7146):1745–1746. [PubMed] [Google Scholar]
- Peltola H., Patja A., Leinikki P., Valle M., Davidkin I., Paunio M. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet. 1998 May 2;351(9112):1327–1328. doi: 10.1016/S0140-6736(98)24018-9. [DOI] [PubMed] [Google Scholar]
- Petrovic M., Roberts R., Ramsay M. Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals. BMJ. 2001 Jan 13;322(7278):82–85. doi: 10.1136/bmj.322.7278.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pollock T. M., Miller E., Lobb J. Severity of whooping cough in England before and after the decline in pertussis immunisation. Arch Dis Child. 1984 Feb;59(2):162–165. doi: 10.1136/adc.59.2.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taylor B., Miller E., Farrington C. P., Petropoulos M. C., Favot-Mayaud I., Li J., Waight P. A. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 1999 Jun 12;353(9169):2026–2029. doi: 10.1016/s0140-6736(99)01239-8. [DOI] [PubMed] [Google Scholar]
- Thompson N. P., Montgomery S. M., Pounder R. E., Wakefield A. J. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet. 1995 Apr 29;345(8957):1071–1074. doi: 10.1016/s0140-6736(95)90816-1. [DOI] [PubMed] [Google Scholar]
- Wakefield A. J., Montgomery S. M. Measles, mumps, rubella vaccine: through a glass, darkly. Adverse Drug React Toxicol Rev. 2000 Dec;19(4):265–292. [PubMed] [Google Scholar]
- Wakefield A. J., Murch S. H., Anthony A., Linnell J., Casson D. M., Malik M., Berelowitz M., Dhillon A. P., Thomson M. A., Harvey P. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998 Feb 28;351(9103):637–641. doi: 10.1016/s0140-6736(97)11096-0. [DOI] [PubMed] [Google Scholar]
- Ward B., DeWals P. Association between measles infection and the occurrence of chronic inflammatory bowel disease. Can Commun Dis Rep. 1997 Jan 1;23(1):1–6. [PubMed] [Google Scholar]
- White J. M., Rush M., Leon S., Ramsay M. E. COVER/Körner 95-1 (April to June 1995). Vaccination coverage statistics for children up to 2 years old in the United Kingdom. Commun Dis Rep CDR Rev. 1995 Nov 10;5(12):R186–R187. [PubMed] [Google Scholar]